|
Volumn 4, Issue 1, 1996, Pages 71-81
|
Global analysis of gastrointestinal safety of a new NSAID, meloxicam
a a a |
Author keywords
cyclooxygenase; gastrointestinal; meloxicam; NSAID; safety
|
Indexed keywords
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
DICLOFENAC;
MELOXICAM;
NEW DRUG;
NONSTEROID ANTIINFLAMMATORY AGENT;
PIROXICAM;
ABDOMINAL PAIN;
ADULT;
AGED;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIGESTIVE SYSTEM ULCER;
DOUBLE BLIND PROCEDURE;
DRUG SAFETY;
DRUG TOLERABILITY;
DYSPEPSIA;
FEMALE;
GASTROINTESTINAL HEMORRHAGE;
GASTROINTESTINAL TOXICITY;
HUMAN;
INTRAMUSCULAR DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
ORAL DRUG ADMINISTRATION;
OSTEOARTHRITIS;
PHARMACEUTICS;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
RECTAL DRUG ADMINISTRATION;
RHEUMATOID ARTHRITIS;
SUSTAINED RELEASE PREPARATION;
|
EID: 0030007321
PISSN: 09254692
EISSN: None
Source Type: Journal
DOI: 10.1007/bf02735561 Document Type: Conference Paper |
Times cited : (26)
|
References (0)
|